BioPorto Financials

BioPorto Stock Summary

BioPorto competes with Spectral Med, Integrated Diagnostics, Euroapi SA, Clinuvel Pharmaceuticals, and Immutep. BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 29 people.

BioPorto Key Financial Ratios

There are many critical financial ratios that BioPorto's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioPorto AS reports annually and quarterly.

BioPorto Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioPorto's current stock value. Our valuation model uses many indicators to compare BioPorto value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioPorto competition to find correlations between indicators driving BioPorto's intrinsic value. More Info.BioPorto AS is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioPorto's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of BioPorto help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioPorto AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioPorto AS based on widely used predictive technical indicators. In general, we focus on analyzing BioPorto Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioPorto's daily price indicators and compare them against related drivers.

When running BioPorto's price analysis, check to measure BioPorto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPorto is operating at the current time. Most of BioPorto's value examination focuses on studying past and present price action to predict the probability of BioPorto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPorto's price. Additionally, you may evaluate how the addition of BioPorto to your portfolios can decrease your overall portfolio volatility.